Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

Recent & Breaking News (TSXV:BTI.H)

Canadian Investment Regulatory Organization Trading Halt - BTI

Canada NewsWire March 21, 2024

Bioasis Provides Corporate Update and Announces Suspension of Operations

GlobeNewswire June 20, 2023

Bioasis Provides Update on Business Operations

GlobeNewswire March 23, 2023

Bioasis Announces AGM Results and Provides Update on Financial Position

GlobeNewswire February 3, 2023

IIROC Trading Resumption - BTI

Canada NewsWire January 23, 2023

Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc

GlobeNewswire January 23, 2023

IIROC Trading Halt - BTI

Canada NewsWire January 23, 2023

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022

GlobeNewswire January 19, 2023

Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders

GlobeNewswire January 11, 2023

Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc

GlobeNewswire December 19, 2022

Bioasis Technologies Inc. Announces Shareholder Webinar

GlobeNewswire December 14, 2022

Bioasis (TSXV:BTI.V) announces merger with Midatech Pharma (NASDAQ:MTP)

Jonathon Brown December 13, 2022

IIROC Trading Resumption - BTI

Canada NewsWire December 13, 2022

Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc

GlobeNewswire December 13, 2022

IIROC Trading Halt - BTI

Canada NewsWire December 13, 2022

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022

GlobeNewswire October 28, 2022

Bioasis Technologies Inc. Announces Stock Option Grants

GlobeNewswire August 8, 2022

Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A

GlobeNewswire July 29, 2022

Bioasis (TSXV:BTI.V) buys epidermal asset for $2.5M

Caroline Egan  June 16, 2022

Bioasis Acquires Phase 2 Ready Rare Orphan EGF Assets

GlobeNewswire June 16, 2022